This study aims to investigate the clinical characteristics, the incidence of myocardial injury, and the influence of myocardial injury on the prognosis in COVID-19 patients. There is no additional examination and treatment for this project.
The epidemic of the COVID-19 has expanded from Wuhan through out China, and is being exported to a growing number of countries. Recently, investigators have revealed that acute myocardial injury is existed in 7.2% patients with COVID-19, and this proportion in patients admitted to the ICU (22.2%) is higher than patients not treated in the ICU (2.0%). Thus, cardiac troponin I (cTNI), the biomarker of cardiac injury, might be a clinical predictor of COVID-19 patient outcomes. This study aims to investigate the clinical characteristics, the incidence of myocardial injury, and the influence of myocardial injury on the prognosis in COVID-19 patients.
Study Type
OBSERVATIONAL
Enrollment
500
no intervention
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
The myocardial injury incidence
The myocardial injury incidence of COVID-19 patients
Time frame: 75 days
The risk factors analysis for the death
The risk factors analysis for the death of COVID-19 patients
Time frame: 75 days
Clinical characteristics
The clinical characteristics description of COVID-19 patients
Time frame: 75 days
Clinical course
The clinical course description of COVID-19 patients
Time frame: 75 days
Cardiovascular comorbidity
The clinical characteristics and prognosis analysis in different cardiovascular comorbidity of COVID-19 patients
Time frame: 75 days
Analysis of causes of death
Analysis of causes of death in COVID-19 patients
Time frame: 75 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.